TMPRSS:ERG fusion in prostate cancer: from experimental approaches to prognostic studies.
Experimental Urology, Department of Urology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria. Electronic address: zoran.culig@i-med.ac.at.
Zoran
Z
Culig
D006801:Humans; D008297:Male; D015514:Oncogene Proteins, Fusion; D011379:Prognosis; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms; D015534:Trans-Activators
D015514:Oncogene Proteins, Fusion; D015534:Trans-Activators; D017430:Prostate-Specific Antigen